Rhinomed continues to invest in furthering our knowledge of the role the nose|MICHAEL JOHNSON,MANAGING DIRECTOR,Rhinomed Ltd 00:10:00
Michael is an experienced leader and innovator with a focus on the successful commercialisation of emerging technologies. Since joining Rhinomed in 2013 he has been responsible for the development of Rhinomed’s nasal technology platform and steering Rhinomed to being one of the world’s leading developers of wearable nasal medical technology. The company has now brought four products to market in the global sleep and snoring, respiratory and nasal congestion markets and is developing applications in the diagnostic and drug delivery markets.
